Nebivolol: A Third-Generation β-Blocker That Augments Vascular Nitric Oxide Release
- 8 August 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (6) , 677-684
- https://doi.org/10.1161/01.cir.102.6.677
Abstract
Background—Nebivolol is a β1-selective adrenergic receptor antagonist with proposed nitric oxide (NO)–mediated vasodilating properties in humans. In this study, we explored whether nebivolol indeed...Keywords
This publication has 16 references indexed in Scilit:
- Activation of nitric oxide synthase by β2‐adrenoceptors in human umbilical vein endothelium in vitroBritish Journal of Pharmacology, 1999
- Adrenocorticotropic Hormone Secretion in Rats Induced by Stimulation with Serotonergic CompoundsJournal of Neuroendocrinology, 1999
- Role of nitric oxide in isoprenaline and sodium nitroprusside‐induced relaxation in human hand veinsBritish Journal of Clinical Pharmacology, 1999
- Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical TrialsJournal of the American College of Cardiology, 1997
- Nitric oxide mediated venodilator effects of nebivolol.British Journal of Clinical Pharmacology, 1994
- Continuous endothelial cells from adult rat heartIn Vitro Cellular & Developmental Biology – Animal, 1993
- Animal Pharmacology of NebivololClinical Drug Investigation, 1991
- Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic AntagonistJournal of Cardiovascular Pharmacology, 1988
- The Additional Properties of Beta Adrenoceptor Blocking DrugsJournal of Cardiovascular Pharmacology, 1986
- β‐ADRENOCEPTOR ANTAGONISTS INHIBIT THE BEHAVIOURAL RESPONSES OF RATS TO INCREASED BRAIN 5‐HYDROXYTRYPTAMINEBritish Journal of Pharmacology, 1978